Neuraptive Therapeutics, Inc

Call
Website
851 Duportail Rd Ste 200
Chesterbrook, PA 19087
+1 (484) 787-3203
https://www.neuraptive.com

Neuraptive Therapeutics, Inc. is a Philadelphia-based company dedicated to developing innovative therapeutics and medical products for physicians and patients affected by peripheral nerve injuries. With a focus on improving the speed and outcomes of peripheral nerve injuries, Neuraptive has in-licensed technology from the University of Texas at Austin, including a novel fusion system for repairing severed peripheral nerves, a specialized drug delivery device for topical administration, and nerve-specific microsurgical instruments to address current limitations in the field of nerve repair.

With their revolutionary surgical treatment kit, NTX-001, Neuraptive aims to revolutionize nerve repair by leveraging the 505(b)(2) development pathway and utilizing previously approved pharmaceutical ingredients presented in sterile solutions. With a significant market opportunity in the US and globally, Neuraptive's products have the potential to make a substantial impact on the lives of millions of patients undergoing nerve repair procedures.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Virtualscopics Inc

Virtualscopics Inc

Founded in 2000, VirtualScopics is an imaging laboratory that provides central reads and quantitative imaging solutions for drug and medical device clinical trials. It offers services in the areas of oncology, rheumatoid arthritis, osteoarthritis, neurology and cardiovascular studies. The laboratory also provides ultrasound, bone scanning and X-ray imaging services. VirtualScopics uses the patented suite of image analysis algorithms to detect, measure and analyze specific biological structures from medical image data. It is staffed with technicians and radiologists and works with several pharmaceutical and biotech companies worldwide. The company also offers clinical protocol design, ongoing image site management, statistical analysis, and image data quality control and inspection services. In addition, VirtualScopics provides services for government departments.

Zynerba Pharmaceuticals, Inc

Zynerba Pharmaceuticals, Inc. is an orphan-focused, neuropsychiatric biopharmaceutical company based in Devon, PA. They are dedicated to developing innovative transdermal cannabinoid treatments for patients with rare neurological diseases, with a particular focus on improving the lives of those battling certain rare conditions. Recently acquired by Harmony Biosciences, Zynerba Pharmaceuticals is at the forefront of pioneering cannabinoid therapies for neuropsychiatric conditions. Their ongoing RECONNECT clinical trial is open for recruitment, offering patients, families, and healthcare providers an opportunity to learn more about Fragile X syndrome and access potential treatments. With a mission to advance science and improve connections, Zynerba Pharmaceuticals is committed to addressing unmet medical needs in the field of rare disorders.Generated from the website

Annovis Bio, Inc

Annovis Bio, Inc is a biopharmaceutical company based in Berwyn, PA, dedicated to developing transformative therapies for neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease. Their innovative approach focuses on reducing neurotoxic proteins and improving axonal transport to enhance the flow of information along nerve cells, offering new hope in addressing the largest unmet need of an aging population. With a pipeline of drugs in development, Annovis Bio aims to reverse the toxic cascade that leads to nerve cell death by targeting impaired axonal transport caused by high levels of neurotoxic proteins. By tackling the root causes of neurodegeneration, including plaques, tangles, and Lewy bodies, the company strives to provide effective treatments for these debilitating conditions.Generated from the website
United States›Pennsylvania›Neuraptive Therapeutics, Inc

Partial Data by Infogroup (c) 2025. All rights reserved.